Skip to main content

Peer Review reports

From: ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma

Original Submission
20 Apr 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
3 Jun 2023 Reviewed Reviewer Report
19 Jun 2023 Reviewed Reviewer Report
17 Jul 2023 Author responded Author comments - Jun Liang
Resubmission - Version 4
17 Jul 2023 Submitted Manuscript version 4
20 Jul 2023 Author responded Author comments - Jun Liang
Resubmission - Version 5
20 Jul 2023 Submitted Manuscript version 5
2 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
22 Nov 2023 Editorially accepted
2 Jan 2024 Article published 10.1186/s12876-023-03059-w

You can find further information about peer review here.

Back to article page